These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 15987205
1. Tuning the regioselectivity of the Staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification. Li J, Chen HN, Chang H, Wang J, Chang CW. Org Lett; 2005 Jul 07; 7(14):3061-4. PubMed ID: 15987205 [Abstract] [Full Text] [Related]
2. Glycodiversification for the optimization of the kanamycin class aminoglycosides. Wang J, Li J, Chen HN, Chang H, Tanifum CT, Liu HH, Czyryca PG, Chang CW. J Med Chem; 2005 Oct 06; 48(20):6271-85. PubMed ID: 16190754 [Abstract] [Full Text] [Related]
3. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues. Li J, Wang J, Czyryca PG, Chang H, Orsak TW, Evanson R, Chang CW. Org Lett; 2004 Apr 29; 6(9):1381-4. PubMed ID: 15101747 [Abstract] [Full Text] [Related]
4. Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity. Bera S, Zhanel GG, Schweizer F. J Med Chem; 2008 Oct 09; 51(19):6160-4. PubMed ID: 18778047 [Abstract] [Full Text] [Related]
5. An aminoglycoside microarray platform for directly monitoring and studying antibiotic resistance. Disney MD, Barrett OJ. Biochemistry; 2007 Oct 09; 46(40):11223-30. PubMed ID: 17867707 [Abstract] [Full Text] [Related]
6. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin B. Kumar V, Jones GS, Blacksberg I, Remers WA, Misiek M, Pursiano TA. J Med Chem; 1980 Jan 09; 23(1):42-9. PubMed ID: 6244410 [Abstract] [Full Text] [Related]
7. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic. Rai R, Chen HN, Czyryca PG, Li J, Chang CW. Org Lett; 2006 Mar 02; 8(5):887-9. PubMed ID: 16494466 [Abstract] [Full Text] [Related]
8. Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents. Bera S, Zhanel GG, Schweizer F. Bioorg Med Chem Lett; 2010 May 15; 20(10):3031-5. PubMed ID: 20413307 [Abstract] [Full Text] [Related]
9. Molecular determinants of antibiotic recognition and resistance by aminoglycoside phosphotransferase (3')-IIIa: a calorimetric and mutational analysis. Kaul M, Barbieri CM, Srinivasan AR, Pilch DS. J Mol Biol; 2007 May 25; 369(1):142-56. PubMed ID: 17418235 [Abstract] [Full Text] [Related]
10. Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity. Bera S, Zhanel GG, Schweizer F. J Med Chem; 2010 May 13; 53(9):3626-31. PubMed ID: 20373816 [Abstract] [Full Text] [Related]
11. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance. Shaul P, Green KD, Rutenberg R, Kramer M, Berkov-Zrihen Y, Breiner-Goldstein E, Garneau-Tsodikova S, Fridman M. Org Biomol Chem; 2011 Jun 07; 9(11):4057-63. PubMed ID: 21365081 [Abstract] [Full Text] [Related]
12. Pyranmycins, a novel class of aminoglycosides with improved acid stability: the SAR of D-pyranoses on ring III of pyranmycin. Chang CW, Hui Y, Elchert B, Wang J, Li J, Rai R. Org Lett; 2002 Dec 26; 4(26):4603-6. PubMed ID: 12489940 [Abstract] [Full Text] [Related]
13. Cross-resistance between some aminoglycoside antibiotics. Onaolapo JA. Afr J Med Med Sci; 1994 Sep 26; 23(3):215-9. PubMed ID: 7604744 [Abstract] [Full Text] [Related]
14. Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacin. Hull R, Klinger JD, Moody EE. J Gen Microbiol; 1976 Jun 26; 94(2):389-94. PubMed ID: 781182 [Abstract] [Full Text] [Related]
15. Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Okazaki A, Avison MB. Antimicrob Agents Chemother; 2007 Jan 26; 51(1):359-60. PubMed ID: 17088477 [Abstract] [Full Text] [Related]
16. Application of the synthetic aminosugars for glycodiversification: synthesis and antimicrobial studies of pyranmycin. Elchert B, Li J, Wang J, Hui Y, Rai R, Ptak R, Ward P, Takemoto JY, Bensaci M, Chang CW. J Org Chem; 2004 Mar 05; 69(5):1513-23. PubMed ID: 14987005 [Abstract] [Full Text] [Related]
17. Regioselective glycosylation of neamine core: a facile entry to kanamycin B related analogues. Chou CH, Wu CS, Chen CH, Lu LD, Kulkarni SS, Wong CH, Hung SC. Org Lett; 2004 Feb 19; 6(4):585-8. PubMed ID: 14961629 [Abstract] [Full Text] [Related]
18. Synthesis of L-carbafuranomycin, an unnatural analogue of the antibiotic amino acid furanomycin. Lee JY, Schiffer G, Jäger V. Org Lett; 2005 Jun 09; 7(12):2317-20. PubMed ID: 15932187 [Abstract] [Full Text] [Related]
19. Synthesis of 3'.4'-dideoxyneamine active aginst kanamycin-resistant E. coli and P. aeruginosa. Umezawa S, Tsuchiya T, Jikihara T, Umezawa H. J Antibiot (Tokyo); 1971 Oct 09; 24(10):711-2. PubMed ID: 5003479 [No Abstract] [Full Text] [Related]